Direct oral anticoagulants plasma levels in patients with atrial fibrillation at the time of bleeding: a pilot prospective study
I Škorňová, M Samoš, T Bolek… - Journal of …, 2021 - journals.lww.com
Patients with atrial fibrillation (AF) on long-term direct oral anticoagulants (DOACs) may be
at higher risk of bleeding because of higher anti-Xa or anti-IIa levels. However, there is no …
at higher risk of bleeding because of higher anti-Xa or anti-IIa levels. However, there is no …
Plasma levels of direct oral anticoagulants in atrial fibrillation patients at the time of embolic stroke: a pilot prospective multicenter study
V Nosáľ, A Petrovičová, I Škorňová, T Bolek… - European Journal of …, 2022 - Springer
Background Patients with atrial fibrillation (AF) who are on long-term direct oral
anticoagulants (DOAC) with low anti-Xa or anti-IIa levels may be at higher risk of recurrent …
anticoagulants (DOAC) with low anti-Xa or anti-IIa levels may be at higher risk of recurrent …
[HTML][HTML] Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants
S Testa, C Legnani, E Antonucci, O Paoletti… - Journal of Thrombosis …, 2019 - Elsevier
Essentials• Currently, DOACs are given at fixed doses and do not require laboratory
monitoring.• Direct oral anticoagulant‐specific measurements were performed at trough and …
monitoring.• Direct oral anticoagulant‐specific measurements were performed at trough and …
[HTML][HTML] Low drug levels and thrombotic complications in high‐risk atrial fibrillation patients treated with direct oral anticoagulants
S Testa, O Paoletti, C Legnani, C Dellanoce… - Journal of Thrombosis …, 2018 - Elsevier
Essentials• Direct oral anticoagulants (DOACs) do not require laboratory monitoring
currently.• DOAC specific measurements were performed at trough in patients with atrial …
currently.• DOAC specific measurements were performed at trough in patients with atrial …
Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study
S Testa, G Palareti, C Legnani, C Dellanoce… - Blood …, 2024 - ashpublications.org
Although effective and safe, treatment with direct oral anticoagulants (DOAC) in atrial
fibrillation (AF) is still associated with thrombotic complications. Whether the measurement of …
fibrillation (AF) is still associated with thrombotic complications. Whether the measurement of …
Interpatient variation in rivaroxaban and apixaban plasma concentrations in routine care
M Gulilat, A Tang, SE Gryn, P Leong-Sit… - Canadian Journal of …, 2017 - Elsevier
Background Direct-acting oral anticoagulants (DOACs) are widely prescribed for stroke
prevention in patients with atrial fibrillation (AF). An important advantage of DOACs is that …
prevention in patients with atrial fibrillation (AF). An important advantage of DOACs is that …
MORE EARLY BLEEDS ASSOCIATED WITH HIGH BASELINE DIRECT ORAL ANTICOAGULANT LEVELS IN ATRIAL FIBRILLATION: THE MAS STUDY
G Palareti, S Testa, C Legnani, C Dellanoce… - Blood …, 2024 - ashpublications.org
Treatment with direct oral anticoagulants (DOAC) in atrial fibrillation (AF) patients is effective
and safe. However, bleeding complications still occur. Whether the measurement of DOAC …
and safe. However, bleeding complications still occur. Whether the measurement of DOAC …
Residual anticoagulation activity in atrial fibrillation patients with temporary interrupted direct oral anticoagulants: Comparisons across 4 drugs
A Sairaku, Y Nakano, Y Onohara, N Hironobe… - Thrombosis …, 2019 - Elsevier
Background Atrial fibrillation (AF) ablation with minimally interrupted direct oral
anticoagulants (DOACs) predominates, possibly raising concern about their remaining …
anticoagulants (DOACs) predominates, possibly raising concern about their remaining …
Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: results observed in four anticoagulation clinics
S Testa, A Tripodi, C Legnani, V Pengo, R Abbate… - Thrombosis research, 2016 - Elsevier
Introduction Direct oral anticoagulant (DOAC) intra-and inter-individual variability was
previously reported, but its magnitude is still considered negligible for patient management …
previously reported, but its magnitude is still considered negligible for patient management …
Drug interaction as a predictor of direct oral anticoagulant drug levels in atrial fibrillation patients
B Hirsh Raccah, A Rottenstreich, N Zacks… - Journal of thrombosis …, 2018 - Springer
Data are limited on the effects of drug interactions on direct-acting oral anticoagulant
(DOAC) levels. We evaluated the effects of the use of interacting drugs on DOAC levels in …
(DOAC) levels. We evaluated the effects of the use of interacting drugs on DOAC levels in …
相关搜索
- drug levels fibrillation patients
- atrial fibrillation plasma levels
- time of bleeding plasma levels
- atrial fibrillation time of bleeding
- fibrillation patients bleeding complications
- drug levels bleeding complications
- fibrillation patients anticoagulation activity
- fibrillation patients embolic stroke
- atrial fibrillation thrombotic events
- anticoagulation clinics plasma levels
- embolic stroke plasma levels
- atrial fibrillation anticoagulation clinics
- fibrillation patients plasma levels
- fibrillation patients thrombotic complications
- fibrillation patients drug interaction